Escrito por estudiantes que aprobaron Inmediatamente disponible después del pago Leer en línea o como PDF ¿Documento equivocado? Cámbialo gratis 4,6 TrustPilot
logo-home
Document preview thumbnail
Vista previa 4 fuera de 299 páginas
Examen

NR 546 Psychopharmacology Final Exam: 300+ Practice Questions & Rationales ()

Document preview thumbnail
Vista previa 4 fuera de 299 páginas

Ace the NR 546 Advanced Psychopharmacology Final Exam with this comprehensive practice question bank. Featuring 300+ multiple-choice questions with detailed rationales, this guide is meticulously aligned with the PMHNP curriculum and covers all key content areas for psychiatric-mental health nurse practitioners. This resource covers every major topic on the exam, including: Functional Neuroanatomy: Brain structures, circuits, and neurotransmitter pathways. Pharmacokinetics & Pharmacodynamics: CYP450 enzymes, drug interactions, and receptor theory. Antidepressants: SSRIs, SNRIs, TCAs, MAOIs – mechanisms, side effects, and clinical use. Antipsychotics: First-generation (FGAs) and second-generation (SGAs) – EPS, metabolic effects, and monitoring. Mood Stabilizers: Lithium, valproic acid, lamotrigine – therapeutic levels, toxicity, and side effects. Anxiolytics & Hypnotics: Benzodiazepines, buspirone, Z-drugs – dependence, withdrawal, and safety. ADHD Pharmacotherapy: Stimulants and non-stimulants – side effects, monitoring, and abuse potential. Substance Use Disorders: Medications for alcohol, opioid, and nicotine use disorders. Neurocognitive Disorders: Alzheimer's disease, cholinesterase inhibitors, and memantine. Ethical & Legal Considerations: Informed consent, involuntary treatment, and documentation. Each question includes a detailed rationale explaining the correct answer and the distractors. Perfect for final review or structured study to build confidence and ensure you pass the NR 546 Final Exam.

Vista previa del contenido

1|Page




NR 546 FINAL EXAM VERSION 1 AND
VERSION 2 | 2026-2027 ACADEMIC YEAR
COMPREHENSIVE PRACTICE QUESTION
BANK FOR PMHNP
PSYCHOPHARMACOLOGY

itsjereguides




# TABLE OF CONTENTS



| Section | Title | Questions |

|---------|-------|-----------|

| 1 | Functional Neuroanatomy & Neurophysiology | 1-30 |

| 2 | Neurotransmission & Signal Transduction | 31-55 |
| 3 | Pharmacokinetics, Pharmacodynamics & CYP450 | 56-80 |
| 4 | Antidepressants: SSRIs, SNRIs, TCAs, MAOIs | 81-115 |

| 5 | Antipsychotics: First-Generation & Second-Generation | 116-145 |

| 6 | Mood Stabilizers: Lithium, Anticonvulsants | 146-175 |

| 7 | Anxiolytics, Sedative-Hypnotics & Sleep Disorders | 176-200 |

| 8 | ADHD Pharmacotherapy & Stimulants | 201-225 |

| 9 | Substance Use Disorders & Pharmacotherapy | 226-250 |
| 10 | Neurocognitive Disorders & Dementia Management | 251-275 |

| 11 | Ethical, Legal & Professional Considerations | 276-300 |

,2|Page

# SECTION 1: FUNCTIONAL NEUROANATOMY & NEUROPHYSIOLOGY



## Questions 1-30


**Question 1**



A psychiatric-mental health nurse practitioner (PMHNP) is evaluating a patient who exhibits
difficulty with speech comprehension but maintains fluent, grammatically correct speech. The
patient's ability to repeat phrases is also impaired. Which area of the brain is MOST likely
affected?



A. Broca's area
B. Wernicke's area

C. Arcuate fasciculus

D. Primary auditory cortex



---



**Correct Answer: B. Wernicke's area**


**Rationale for Correct Answer:**

Wernicke's area, located in the superior temporal gyrus of the dominant hemisphere, is
responsible for language comprehension. Damage to this area results in Wernicke's (receptive)
aphasia, characterized by fluent but nonsensical speech, impaired comprehension, and difficulty
with repetition. This patient's presentation of impaired comprehension with fluent speech is
classic for Wernicke's aphasia .



**Rationale for Incorrect Answers:**

,3|Page

- **A. Broca's area:** Damage to Broca's area results in expressive aphasia, characterized by
non-fluent, effortful speech with relatively preserved comprehension. This patient has fluent
speech, so Broca's area is not the primary site of damage.

- **C. Arcuate fasciculus:** The arcuate fasciculus connects Broca's and Wernicke's areas.
Damage here results in conduction aphasia, characterized by fluent speech, preserved
comprehension, but impaired repetition. This patient has impaired comprehension as well,
making Wernicke's area the more likely site.

- **D. Primary auditory cortex:** Damage to the primary auditory cortex results in cortical
deafness or auditory agnosia, not the specific language comprehension deficit seen in Wernicke's
aphasia.



---



**Question 2**


The PMHNP is explaining the role of the limbic system in psychiatric disorders to a patient.
Which of the following structures is a key component of the limbic system and is primarily
associated with fear response and emotional memory?


A. Hippocampus

B. Amygdala

C. Basal ganglia

D. Cerebellum



**Correct Answer: B. Amygdala**


**Rationale for Correct Answer:**

The amygdala is a key structure of the limbic system that plays a central role in processing
emotions, particularly fear and anxiety. It is also involved in emotional memory formation.
Dysregulation of the amygdala is implicated in anxiety disorders, PTSD, and mood disorders .

, 4|Page

**Rationale for Incorrect Answers:**



- **A. Hippocampus:** The hippocampus is primarily involved in memory formation and
spatial navigation, not specifically the fear response. While it is part of the limbic system, its
primary role is different from the amygdala.

- **C. Basal ganglia:** The basal ganglia are a group of subcortical structures primarily
involved in motor control and habit learning. They are not a primary component of the limbic
system.

- **D. Cerebellum:** The cerebellum is primarily involved in coordination, balance, and motor
learning. It is not considered a key structure of the limbic system.



---



**Question 3**



A patient presents with symptoms of depression, including anhedonia, lack of motivation, and
decreased energy. Based on the monoamine hypothesis, which neurotransmitter deficiency is
MOST likely contributing to these symptoms?



A. Serotonin deficiency

B. Norepinephrine deficiency
C. Dopamine deficiency

D. GABA deficiency



**Correct Answer: C. Dopamine deficiency**



**Rationale for Correct Answer:**

According to the monoamine hypothesis of depression, different monoamine neurotransmitter
deficiencies contribute to different symptom clusters. Dopamine (DA) deficiency is associated

Información del documento

Subido en
11 de julio de 2026
Número de páginas
299
Escrito en
2025/2026
Tipo
Examen
Contiene
Preguntas y respuestas
$27.49

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
ITSJEREGUIDES
5.0
(1)
Vendido
11
Seguidores
1
Artículos
1436
Última venta
3 días hace


Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes